1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Bone Sarcoma Global Clinical Trials Review, H1, 2014

Bone Sarcoma Global Clinical Trials Review, H1, 2014

  • March 2014
  • -
  • Global Data
  • -
  • 137 pages

Bone Sarcoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Bone Sarcoma Global Clinical Trials Review, H1, 2014" provides data on the Bone Sarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Sarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bone Sarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Bone Sarcoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bone Sarcoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bone Sarcoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bone Sarcoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bone Sarcoma 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Bone Sarcoma Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Takeda Pharmaceutical Company Limited 34
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 34
Eli Lilly and Company 35
Clinical Trial Overview of Eli Lilly and Company 35
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Merck and Co., Inc. 37
Clinical Trial Overview of Merck and Co., Inc. 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Celgene Corporation 39
Clinical Trial Overview of Celgene Corporation 39
Amgen Inc. 40
Clinical Trial Overview of Amgen Inc. 40
ACORN Research, LLC 41
Clinical Trial Overview of ACORN Research, LLC 41
Clinical Trial Overview of Top Institutes / Government 42
National Cancer Institute 42
Clinical Trial Overview of National Cancer Institute 42
Children's Oncology Group 49
Clinical Trial Overview of Children's Oncology Group 49
Memorial Sloan Kettering Cancer Center 51
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 51
The University of Texas M. D. Anderson Cancer Center 53
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 53
European Organization for Research and Treatment of Cancer 55
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 55
Massachusetts General Hospital 56
Clinical Trial Overview of Massachusetts General Hospital 56
Stanford University 57
Clinical Trial Overview of Stanford University 57
Sidney Kimmel Comprehensive Cancer Center 58
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 58
Five Key Clinical Profiles 59
Appendix 134
Abbreviations 134
Definitions 134
Research Methodology 135
Secondary Research 135
About GlobalData 136
Contact Us 136
Disclaimer 136
Source 137

List of Tables
Bone Sarcoma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bone Sarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bone Sarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bone Sarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Bone Sarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bone Sarcoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bone Sarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Bone Sarcoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Bone Sarcoma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Bone Sarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bone Sarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bone Sarcoma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Bone Sarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bone Sarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bone Sarcoma Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Bone Sarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Bone Sarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bone Sarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bone Sarcoma Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Bone Sarcoma Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Bone Sarcoma Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Bone Sarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Bone Sarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Bone Sarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Bone Sarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Bone Sarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 34
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 35
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 36
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 37
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 38
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 39
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 40
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ACORN Research, LLC, 2014* 41
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 42
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 49
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 51
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 53
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 55
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 56
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 57
Bone Sarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014* 58

List of Figures
Bone Sarcoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bone Sarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bone Sarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bone Sarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Bone Sarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bone Sarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Bone Sarcoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Bone Sarcoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Bone Sarcoma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Bone Sarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bone Sarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bone Sarcoma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Bone Sarcoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bone Sarcoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bone Sarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Bone Sarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bone Sarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bone Sarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Bone Sarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Bone Sarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Bone Sarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Bone Sarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 135

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.